Doctor profile · Federal record
Dr. Mia Talamantes, PA-C
Physician Assistant · New York, NY
- NPI 1437700887
- 7 yrs on file
- Female
- Solo practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
177 Fort Washington Ave Rm 124-A
New York, NY 100323733
(212) 342-3622 - Additional location
-
177 Fort Washington Ave
New York, NY 100323733
(212) 305-8715 - Additional location
-
622 W 168Th St
New York, NY 100323720
(212) 305-4725 - Mailing address
-
195 Spring St Apt 19
New York, NY 100123647
Credentials & registration
- NPI registered
- September 2019 — 7 yrs on file
- Specialty taxonomy
- 363A00000X — NUCC code
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1437700887. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$161
Transactions
9
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $94.65 | |
| Actelion Pharmaceuticals US, INC. | 2 | $50.44 | |
| Janssen Pharmaceuticals, INC | 1 | $16.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
143
Patients
55
Total drug cost
$31,434
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 65 | 35 | $1,766 |
| Atorvastatin Calcium | Generic | 29 | 20 | $538 |
| Eliquis (Apixaban) | Brand | 14 | 0 | $8,021 |
| Metoprolol Succinate | Generic | 13 | 0 | $327 |
| Brilinta (Ticagrelor) | Brand | 11 | 0 | $13,751 |
| Jardiance (Empagliflozin) | Brand | 11 | 0 | $7,031 |
Frequently asked questions
What is Dr. Mia Talamantes's medical specialty?
Dr. Mia Talamantes practices Physician Assistant in New York, NY.
Where does Dr. Mia Talamantes practice?
Dr. Mia Talamantes practices at 177 Fort Washington Ave Rm 124-A, New York, NY 100323733. Office phone: 2123423622.
What is Dr. Mia Talamantes's NPI?
Dr. Mia Talamantes's National Provider Identifier (NPI) is 1437700887, issued by NPPES.